The setup
Among the CMIOs and clinical informatics leads we track, Intermountain is no longer a hypothesis on the point-of-care workflow. It is the default. The transition happened over six weeks, not the eighteen-month timeline the trade press kept publishing. This briefing reconstructs the inflection point in five sections.
The specific change is narrow: Intermountain now reshapes the point-of-care workflow as a first-class capability, not as a configuration option behind three menus. That sounds like a UX detail. It is a positioning move. The default surface of any product is the only one most CMIOs and clinical informatics leads ever touch.
The data
The buy-side has already moved. Five of the top ten sell-side notes published in the last six weeks raised price targets on Intermountain's exposure to point-of-care workflow, with the median upgrade citing the same three drivers: faster deployment, lower time-to-decision, and reduced switching cost.
What that means in plain English: Intermountain has stopped competing on capability and started competing on integration cost. Capability arguments still appear in keynotes. They have largely disappeared from procurement meetings. The argument that closes deals now is the cost of switching, and Intermountain has made theirs lower than anyone else's.
A re-architecture, shipped under a release-notes title — and the clinical informatics stack priced it accordingly.
The implication
The immediate impact is on procurement: vendors who priced against the assumption that the point-of-care workflow would remain capability-led need to reprice against an integration-cost benchmark. Several have already started. The ones who have not will lose Q3 deals they expected to win.
Watch the partnership ecosystem. Intermountain's move on the point-of-care workflow pulls the integration partners into a clearer hierarchy: tier-one (deep integration, co-marketing), tier-two (certified, no co-marketing), tier-three (compatibility-only). The tier-one slots are filling. The tier-two slots are where the next twelve months of M&A happens.
What to watch
The early indicators that this is or is not playing out the way the data suggests:
- Whether the second mover ships a comparable point-of-care workflow primitive within ninety days, or holds back to differentiate on governance. Both are signals, in opposite directions.
- Renewal cohort behavior in Q3. If expansion rates hold above 80% and consolidation rates above 50%, the thesis here is intact. If either softens, re-underwrite.
- The hiring pattern at the top three competitors. We are watching for the point-of-care workflow platform leads being recruited out of Intermountain's ecosystem — that is the leading indicator for a competitive response.
- Partnership tier announcements from the integration ecosystem. A consolidation here precedes the M&A consolidation by roughly two quarters.
Frequently asked
- Is this a one-off product release or a category shift?
- A category shift. The same primitive Intermountain reshapes here is showing up across at least two adjacent vendors' roadmaps. The framing differs; the underlying move on point-of-care workflow does not.
- How fast is the competitive response likely to land?
- On the order of two quarters for a credible parity feature, four quarters for a differentiated alternative. The intermediate window is the buying opportunity. The post-parity window is a margin compression story.
- What does this mean for incumbents whose the point-of-care workflow business depends on the old model?
- Either reprice or repackage. The incumbents who reprice within ninety days hold the renewal cohort. The ones who attempt to repackage without repricing lose the lower half of the install base within a year. Both outcomes are visible in prior category transitions.
We will keep tracking the metrics named above. If renewal cohorts hold, the thesis runs. If they soften, the desk re-underwrites. Either way, the slow-moving piece — the structural shift in how CMIOs and clinical informatics leads buy the point-of-care workflow — is already in motion, and that part does not reverse.